Crypto trading bots with full source code you can verify

$10,000 to $195,626

APEX, backtested over 6.3 years on ADA at its highest setting (0.5% risk, 12 positions), profitable in every calendar year after real fees. CARRY, a delta-neutral funding yield on BTC and ETH. Both ship with full source code and one command that re-derives their figures on your own machine.

See both strategies ↓ How they were vetted

The strategies

Two strategies, two different sources of return.

The headline record for each is here. The full evidence, every chart, the risk profile and the research behind the figures, is on each strategy’s own page, rather than behind an email form.

2020–2026 · 6,576 trades

APEX

60.0% a year+$185,626 on a $10K account

Backtest, Jan 2020 – May 2026, at the highest setting (0.5% risk, 12 positions): $10,000 became $195,626

A systematic short on the ADA-USDT perpetual. One instrument, one venue, profitable in every calendar year of the backtest.

$399 One-time · USDC · sales final, two exceptions

Full record ↗ Get APEX ↗

BTC / ETH · 2,190 settlements each

CARRY

12.5% a year+$1,250 a year on a $10K account

Net APR on total equity at 3.4x reference leverage with a 25% tail reserve, two-year backtest average

A delta-neutral funding yield on BTC and ETH perpetuals. Nothing is forecast, nothing is timed, and there is no signal.

$199 One-time · USDC · sales final, two exceptions

Full research ↗ Get CARRY ↗

APEX + CARRY

Bundle

One payment, both licences, $99 less than buying them apart.

$499 One-time · both licences · USDC · sales final, two exceptions

Get both ↗

The method

Four gates every strategy is held to.

Each one closes a specific way a backtest can flatter itself.

Gate 01

A dated pre-registration

The research line’s pre-registrations: each study’s hypothesis and the conditions that would end it. Their SHA-256 manifest is anchored in the Bitcoin blockchain by OpenTimestamps, so anyone can prove the documents have not changed since 11 September 2026, without asking us. The stamp does not prove they predate the research, which ran earlier. APEX’s final settings, the 1:5 target and the 1.25% stop, come from a documented parameter sweep, and the published statistics are corrected for it.

Gate 02

Out-of-sample results

A walk-forward split with the test half reported as it came out, and the headline deflated for the size of the search. For APEX the test half stays positive at the product’s own costs (t 2.42), and the deflated scores are published in the pre-sale agreement.

Gate 03

A costed execution study

Real venue fees, real funding, and a measured cost for resting at the back of the order-book queue, charged to every trade. Before the bot arms, a probe checks that your own exchange account can do everything the strategy relies on.

Gate 04

The drawdown, stated first

Worst peak-to-trough on the full record, printed beside the return rather than beneath it. If you can't hold the drawdown, the return isn't available to you.

After you buy

From payment to a verified package on your machine.

Delivery, step by step

Automatic, then yours.

Pay in USDC on Solana and the licence key and download arrive by email the moment the payment confirms. Unpack it, run the verify command, and the research figures are re-derived on your own machine. Then paper trade first, and start live small.

The terminal lines are the real verify run. Order and licence numbers are masked.

Here is what to consider before buying.

Is this a signal service or a managed fund?

Neither. You buy software and the research behind it, run it on your own venue account, and keep custody throughout. Apexstoa never takes deposits, never trades on your behalf, and takes no performance fee.

Why is access limited?

Because every copy places the same order at the same price at the same moment, and they end up competing with each other to get filled. Past a certain point, more users means worse results for everyone already using it. Closing access is the only way to protect what buyers paid for.

What happens when access closes?

Sales stop. Everyone who already bought keeps everything (the bot, the source, the research and any corrections) and continues to receive updates. It does not quietly reopen later under a different name.

Why does it only trade some of the signals?

It rests a limit order at a specific price and trades only if the market comes to it. Signals that never reach the level simply don't become trades and cost nothing. Every figure on the listing is computed on trades the backtest treats as filled: if the price reached the resting level, the order is assumed to fill there. That is a simulation, not an observed fill, and the package says so plainly.

What if I get stuck setting it up?

Write to apexstoa@proton.me. Setup help is available by email: connecting your own exchange account, creating an API key with the right permissions, and getting the first dry run to pass. The package ships SETUP.md, which walks the whole install, and TROUBLESHOOTING.md, which covers the refusals and errors you are most likely to hit. If those do not get you there, someone will answer.

Can I get a refund?

Sales are final as a general rule: you receive the complete source code, the engine and the research record on purchase, and none of that can be handed back once it's been delivered. Two things qualify that. If a published figure that the product's own verify command checks (apex.cli verify for APEX, carry.cli verify for CARRY) does not reproduce on your machine, that is a refund. And where a defect in the software cannot be fixed by any update, the fee may be refunded in whole or in part at the seller's discretion, exercised in good faith. Refunds are not available for trading losses, for your own configuration or exchange choice, or for changing your mind about the strategy. The full terms are in the pre-sale agreement. That is also why everything material to the decision sits on this page before you pay: the returns, the drawdowns, the worst month, the longest losing run, and the fact that these are backtested rather than live results. Read it, take the time you need, and only buy if the risk profile suits you.

Can I pay by card?

Not yet. Crypto only for now. Card payment is on the roadmap.

Get started

Read the disclosures. Then decide.

Everything that bears on the decision is published here and in the pre-sale agreement: the returns, the drawdowns and the terms. Read it once, then choose the setting that suits you.

Every performance figure for these products comes from a backtest, a simulation over historical data, and trading leveraged cryptocurrency derivatives can lose you more than your deposit. APEX has a maximum historical drawdown of −71.6% at its highest setting and −42.0% at the conservative setting that ships (−71.9% and −44.6% with no limit on open positions). CARRY’s figures come from two years of settlements, and the funding regime that produces its yield is decaying.

Nothing here is investment advice. You run the software on your own exchange account and keep custody of your funds. The complete risk statement is in the pre-sale agreement, which you accept before any payment.

Sales are final, with two exceptions set out in the pre-sale agreement: a published figure that the product's verify command checks and that doesn't reproduce is refunded in full, and a defect no update can fix may be refunded at the seller's discretion. Otherwise the source code and the research record are delivered on purchase and can't be returned, which is exactly why every number that bears on the decision is above, before you pay, rather than in terms you'd have to go looking for.

Buy APEX · $399 Buy CARRY · $199 Buy both · $499 Why APEX access is limited

One-time, in crypto. Both are on sale now, and the bundle is $99 below buying them apart. Nothing here is a subscription and there is no performance fee on either.